Driehaus Capital Management’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-763,486
| Closed | -$2.11M | – | 501 |
|
|
2025
Q1 | $2.11M | Sell |
763,486
-898,360
| -54% | -$2.48M | 0.02% | 320 |
|
|
2024
Q4 | $9.21M | Sell |
1,661,846
-429,955
| -21% | -$2.38M | 0.08% | 260 |
|
|
2024
Q3 | $17.4M | Buy |
2,091,801
+1,007,896
| +93% | +$8.41M | 0.15% | 188 |
|
|
2024
Q2 | $7.38M | Hold |
1,083,905
| – | – | 0.07% | 237 |
|
|
2024
Q1 | $7.11M | Sell |
1,083,905
-46,147
| -4% | -$303K | 0.07% | 261 |
|
|
2023
Q4 | $7.33M | Sell |
1,130,052
-487,868
| -30% | -$3.17M | 0.09% | 251 |
|
|
2023
Q3 | $8.14M | Sell |
1,617,920
-3,859
| -0.2% | -$19.4K | 0.11% | 234 |
|
|
2023
Q2 | $14.2M | Sell |
1,621,779
-847,733
| -34% | -$7.42M | 0.18% | 179 |
|
|
2023
Q1 | $29.2M | Buy |
2,469,512
+175,136
| +8% | +$2.07M | 0.41% | 65 |
|
|
2022
Q4 | $23.4M | Buy |
2,294,376
+696,447
| +44% | +$7.09M | 0.35% | 93 |
|
|
2022
Q3 | $9.41M | Buy |
1,597,929
+1,387,855
| +661% | +$8.17M | 0.14% | 203 |
|
|
2022
Q2 | $521K | Buy |
210,074
+174,974
| +499% | +$434K | 0.01% | 311 |
|
|
2022
Q1 | $104K | Buy |
+35,100
| New | +$104K | ﹤0.01% | 376 |
|